As of 2025-10-15, the EV/EBITDA ratio of Inari Medical Inc (NARI) is -138.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NARI's latest enterprise value is 4,641.90 mil USD. NARI's TTM EBITDA according to its financial statements is -33.52 mil USD. Dividing these 2 quantities gives us the above NARI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 10.1x | 9.4x |
| Forward P/E multiples | 12.7x - 19.8x | 17.0x |
| Fair Price | (6.55) - (5.06) | (6.85) |
| Upside | -108.2% - -106.3% | -108.6% |
| Date | EV/EBITDA |